CORRECTION article

Front. Oncol., 07 July 2025

Sec. Molecular and Cellular Oncology

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1643772

Correction: Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway

  • 1. Department of Clinical Laboratory, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China

  • 2. Department of Medical Laboratory, Qingdao Sixth People’s Hospital, Qingdao, China

  • 3. The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China

  • 4. Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, United States

  • 5. The Third Comprehensive Department, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China

  • 6. State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China

  • 7. Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, China

Article metrics

View details

854

Views

305

Downloads

In the published article, there was an error in Figure 5A and Figure 6A as published. During an AI-assisted image integrity review of our published work, we identified inadvertent duplications in Figure 5A and Figure 6A (Migration, PRKCI and shcontrol; Wound healing assay, 0h shcontrol and shPRKCI, 24h Vector and shPRKCI). This was an oversight during figure preparation and does not affect the study’s conclusions. We have since located the original data and prepared a corrected version of the figure. The corrected Figure 5A and Figure 6A and its caption appear below.

Figure 5

Figure 6

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

PRKCI, osteosarcoma, proliferation, Akt/mTOR signaling pathway, therapy

Citation

Qu L, Xin Y, Feng J, Ren X, Li Z, Chen X, Miao G, Chen J, Sun C and Lu Y (2025) Correction: Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway. Front. Oncol. 15:1643772. doi: 10.3389/fonc.2025.1643772

Received

09 June 2025

Accepted

23 June 2025

Published

07 July 2025

Volume

15 - 2025

Edited and reviewed by

Tinghe Yu, Chongqing Medical University, China

Updates

Copyright

*Correspondence: Jiankun Chen, ; Chengming Sun, ; Yue Lu,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics